Search hospitals > Pennsylvania > Philadelphia
Fox Chase Cancer Center
Claim this profilePhiladelphia, Pennsylvania 19111
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Tumors
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
1153 reported clinical trials
67 medical researchers
Summary
Fox Chase Cancer Center is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Cancer, Lung Cancer, Tumors, Non-Small Cell Lung Cancer, Breast Cancer and other specialties. Fox Chase Cancer Center is involved with conducting 1,153 clinical trials across 617 conditions. There are 67 research doctors associated with this hospital, such as Anthony J. Olszanski, Jessica Bauman, MD, Hossein Borghaei, and Margaret von Mehren, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Anthony J. OlszanskiFox Chase Cancer Center3 years of reported clinical research
Expert in Solid Tumors
Studies Tumors
17 reported clinical trials
26 drugs studied
Jessica Bauman, MDFox Chase Cancer Center3 years of reported clinical research
Studies Lung Cancer
Studies Solid Tumors
12 reported clinical trials
25 drugs studied
Hossein BorghaeiFox Chase Cancer Center5 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
11 reported clinical trials
21 drugs studied
Margaret von Mehren, MDFox Chase Cancer Center3 years of reported clinical research
Studies Sarcoma
Studies Soft Tissue Sarcoma
11 reported clinical trials
44 drugs studied
Clinical Trials running at Fox Chase Cancer Center
Breast Cancer
Cancer
Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Solid Tumors
Tumors
Lymphoma
Recurrence
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
NUV-868 + Olaparib/Enzalutamide
for Cancer
This trial tests a new drug, NUV-868, taken regularly by mouth, in patients with advanced cancers. It aims to find the best dose and see if combining it with other drugs can improve treatment. The study includes patients with advanced solid tumors and a specific type of prostate cancer.
Recruiting1 award Phase 1 & 211 criteria
TAK-500 + Pembrolizumab
for Advanced Solid Cancers
This trial is testing a new drug called TAK-500, alone or with pembrolizumab, in adults with advanced or spreading solid tumors. The goal is to see if TAK-500 is safe and effective in shrinking these tumors.
Recruiting1 award Phase 1 & 213 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Fox Chase Cancer Center?
Fox Chase Cancer Center is a medical facility located in Philadelphia, Pennsylvania. This center is recognized for care of Cancer, Lung Cancer, Tumors, Non-Small Cell Lung Cancer, Breast Cancer and other specialties. Fox Chase Cancer Center is involved with conducting 1,153 clinical trials across 617 conditions. There are 67 research doctors associated with this hospital, such as Anthony J. Olszanski, Jessica Bauman, MD, Hossein Borghaei, and Margaret von Mehren, MD.
Where is Fox Chase Cancer Center located?
**Fox Chase Cancer Center Location and Directions:**
- **Address:** 333 Cottman Avenue, Philadelphia, PA 19111.
- **By Car:** Accessible via I-76 E, exit 346A for PA-63 W towards Wynnefield.
- **Public Transportation:** Buses and trains serve the area, with detailed directions on the center's website.
Who should I call to ask about financial aid or insurance network?
**Fox Chase Cancer Center Financial Assistance and Insurance Information:**
- **Financial Assistance:** For charity care and other financial assistance, contact 888-336-5897 or visit the website. Financial counselors are available Monday through Friday, 8 am to 5 pm. For billing questions regarding hospital stays or services on or after October 1, 2022, call 888-336-5897. For services before this date, call 888-378-0357.
- **Insurance Inquiries:** Contact the Patient Financial Services Department at 888-366-5897 before your visit to confirm participation with your insurance.
- **Additional Support:** Temple Health hospitals, including Fox Chase Cancer Center, offer free or reduced-priced care for qualifying individuals and assistance with government-funded insurance programs and ACA Marketplace Plans.
What insurance does Fox Chase Cancer Center accept?
Fox Chase Cancer Center accepts a wide range of health insurance plans, such as Aetna, HMO, PPO, and POS. Patients are advised to contact their insurance company to understand their benefits and liabilities. This center stands out for accepting all insurance, ensuring broad access for patients.
What awards or recognition has Fox Chase Cancer Center received?
Fox Chase Cancer Center, located in Philadelphia, Pennsylvania, is a National Cancer Institute-designated Comprehensive Cancer Center renowned for its pioneering research and exceptional patient care. It has been honored with two Nobel Prizes, a Kyoto Prize, and a Lasker Prize, highlighting the significant achievements of its staff. Furthermore, it is recognized as one of the top cancer hospitals in the United States by U.S. News & World Report.